-
Symbol
-
TERN on Nasdaq
-
Investment type
-
Equity - Shares of Stock
-
Class
-
Common Stock, $0.0001 par value per share (the "Shares")
-
Latest Disclosed Ownership
-
8.14M shares
-
Security Ownership
-
9.6%
Soleus Capital Master Fund, L.P. ownership in Terns Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (the "Shares") (TERN)
2025-02-11 - Soleus Capital Master Fund, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 8.14M shares of Terns Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (the "Shares") (TERN).
This represents 9.6% percent ownership of the company.